These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3893599)

  • 1. Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial. II. The incidence of compliance problems, side-effects, neurotic symptoms and depression.
    Curson DA; Barnes TR; Bamber RW; Platt SD; Hirsch SR; Duffy JC
    Br J Psychiatry; 1985 May; 146():469-74. PubMed ID: 3893599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial. III. Relapse postponement or relapse prevention? The implications for long-term outcome.
    Curson DA; Barnes TR; Bamber RW; Platt SD; Hirsch SR; Duffy JC
    Br J Psychiatry; 1985 May; 146():474-80. PubMed ID: 3893600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial I. Course of illness, stability of diagnosis, and the role of a special maintenance clinic.
    Curson DA; Barnes TR; Bamber RW; Platt SD; Hirsch SR; Duffy JC
    Br J Psychiatry; 1985 May; 146():464-9. PubMed ID: 3893598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side effects during long-term treatment with depot antipsychotic medication.
    Cookson JC
    Clin Neuropharmacol; 1991; 14 Suppl 2():S24-30; discussion S30-2. PubMed ID: 1751940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients.
    Inderbitzin LB; Lewine RR; Scheller-Gilkey G; Swofford CD; Egan GJ; Gloersen BA; Vidanagama BP; Waternaux C
    Am J Psychiatry; 1994 Dec; 151(12):1753-9. PubMed ID: 7977881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors related to tardive dyskinesia.
    Chouinard G; Annable L; Ross-Chouinard A; Nestoros JN
    Am J Psychiatry; 1979 Jan; 136(1):79-82. PubMed ID: 31802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depot fluphenazine: risk/benefit ratio.
    Glazer WM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluphenazine enanthate in the outpatient treatment of late paraphrenia.
    Raskind M; Alvarez C; Herlin S
    J Am Geriatr Soc; 1979 Oct; 27(10):459-63. PubMed ID: 469146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response.
    Marder SR; Midha KK; Van Putten T; Aravagiri M; Hawes EM; Hubbard JW; McKay G; Mintz J
    Br J Psychiatry; 1991 May; 158():658-65. PubMed ID: 1860020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.
    Hirsch SR; Gaind R; Rohde PD; Stevens BC; Wing JK
    Br Med J; 1973 Mar; 1(5854):633-7. PubMed ID: 4571196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind comparison of fluspirilene and fluphenazine decanoate in schizophrenia.
    Russell N; Landmark J; Merskey H; Turpin T
    Can J Psychiatry; 1982 Nov; 27(7):593-6. PubMed ID: 7172160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depot fluphenazine decanoate and enanthate for schizophrenia.
    David A; Adams CE; Eisenbruch M; Quraishi S; Rathbone J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD000307. PubMed ID: 15674872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dystonia. The benefits of time.
    Cooper SJ; Doherty MM; King DJ
    Br J Psychiatry; 1989 Jul; 155():113-5. PubMed ID: 2691000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
    Walker CA
    Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics.
    Mandel MR; Severe JB; Schooler NR; Gelenberg AJ; Mieske M
    Arch Gen Psychiatry; 1982 Feb; 39(2):197-203. PubMed ID: 6121543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suicide associated with akathisia and depot fluphenazine treatment.
    Shear MK; Frances A; Weiden P
    J Clin Psychopharmacol; 1983 Aug; 3(4):235-6. PubMed ID: 6886035
    [No Abstract]   [Full Text] [Related]  

  • 18. Follow-up study of 281 schizophrenic patients treated with high dosage fluphenazine decanoate.
    Steiner S; Nagy C
    Int Pharmacopsychiatry; 1981; 16(3):184-92. PubMed ID: 7319750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical observations of treatment with Lyorodin-depot (Jenapharm)].
    Pirozynski T; Chiriţă V; Cosmovici N; Offenberg C; Chiriac ME; Marinescu V; Cojocaru M; Berlescu M; Mungiu A
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(3):501-9. PubMed ID: 2700035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once weekly pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
    McCreadie R; Mackie M; Morrison D; Kidd J
    Br J Psychiatry; 1982 Mar; 140():280-6. PubMed ID: 7093596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.